Antiretroviral Therapy for the Prevention of HIV-1 Transmission
about
The global HIV epidemic: What the pathologist needs to know.Viral Infections and Obesity.HIV care in Yangon, Myanmar; successes, challenges and implications for policy.Condomless sex and HIV transmission among serodifferent couples: current evidence and recommendations.Recent mobile health interventions to support medication adherence among HIV-positive MSM.The potential impact and cost of focusing HIV prevention on young women and men: A modeling analysis in western Kenya.Seek, test, treat: substance-using women in the HIV treatment cascade in South Africa.Factors associated with pre-treatment HIV RNA: application for the use of abacavir and rilpivirine as the first-line regimen for HIV-infected patients in resource-limited settings.Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052.Differentiated Human Immunodeficiency Virus RNA Monitoring in Resource-Limited Settings: An Economic AnalysisAwareness and perceived fairness of Option B+ in Malawi: A population-level perspectiveCare cascade structural intervention versus standard of care in the diagnosis and treatment of HIV in China: a cluster-randomized controlled trial protocol.Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up.Risk Factor Associated with Negative Spouse HIV Seroconversion among Sero-Different Couples: A Nested Case-Control Retrospective Survey Study in 30 Counties in Rural China.A longitudinal cohort study of HIV 'treatment as prevention' in gay, bisexual and other men who have sex with men: the Treatment with Antiretrovirals and their Impact on Positive And Negative men (TAIPAN) study protocol."Since both of us are using antiretrovirals, we have been supportive to each other": facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya.The Risk of Sexually Transmitted Infection and Its Influence on Condom Use among Pregnant Women in the Kintampo North Municipality of GhanaAssociation between engagement in-care and mortality in HIV-positive persons.HIV Futures 8: Protocol for a Repeated Cross-sectional and Longitudinal Survey of People Living with HIV in AustraliaPrevention of Sexually Transmitted Diseases in HIV-Infected Individuals.Traditional health practitioners' management of HIV/AIDS in rural South Africa in the era of widespread antiretroviral therapy.Phased implementation of spaced clinic visits for stable HIV-positive patients in Rwanda to support Treat All.HIV Prevention Among Transgender Populations: Knowledge Gaps and Evidence for Action.A Comparison of Hepatitis B Virus Infection in HIV-infected and HIV-uninfected Participants Enrolled in a Multi-National Clinical Trial: HPTN 052.The Metropolitan Atlanta community adolescent rapid testing initiative study: closing the gaps in HIV care among youth in Atlanta, Georgia, USABehavioural, not biological, factors drive the HCV epidemic among HIV-positive MSM: HCV and HIV modelling analysis including HCV treatment-as-prevention impact.Trends in ART Prescription and Viral Suppression Among HIV-Positive Young Adults in Care in the United States, 2009-2013.HIV Provider Experiences Engaging and Retaining Patients in HIV Care and Treatment: "A Soft Place to Fall".Penile Immune Activation and Risk of HIV Shedding: A Prospective Cohort Study.A Longitudinal Analysis of Treatment Optimism and HIV Acquisition and Transmission Risk Behaviors Among Black Men Who Have Sex with Men in HPTN 061.Assessing cervical intraepithelial neoplasia as an indicator disease for HIV in a low endemic setting: a population-based register study.Combination antiretroviral therapy and cancer risk.Using Population-Size Estimation and Cross-sectional Survey Methods to Evaluate HIV Service Coverage Among Key Populations in Burkina Faso and Togo.Tenofovir alafenamide, emtricitabine, elvitegravir, and cobicistat combination therapy for the treatment of HIV."You just can't trust everybody": the impact of sexual risk, partner type and perceived partner trustworthiness on HIV-status disclosure decisions among HIV-positive black gay and bisexual men.Polyvalent vaccine approaches to combat HIV-1 diversityComplex immune correlates of protection in HIV-1 vaccine efficacy trials.Pre-exposure prophylaxis prescribing and retention in care among heterosexual women at a community-based comprehensive sexual health clinic.Proviral Latency, Persistent Human Immunodeficiency Virus Infection, and the Development of Latency Reversing Agents.The changing face of an epidemic: healthy old age with HIV.
P2860
Q30234308-51306E27-1DED-4328-B07B-296C1EE4F89FQ30235298-157DB3B7-4824-4E48-AD87-E565A2EBCFC2Q30378383-2745C26B-2159-4484-A76B-59BD415325E0Q30401071-87407321-3450-411F-88EE-F494F2823404Q33455183-080FE5E1-3645-4216-B442-E315BD1D1F16Q33558726-16389A6D-A52C-43FF-BCE7-980A7B6D686FQ33604304-AAC858A4-83A3-4DA1-94F5-F2B02C0F1AA2Q33644568-73A31B46-A25E-417C-B40D-1D33CC404683Q33648264-D2D88713-8198-4CCD-AB17-A9FA5953B60CQ33737122-22A745B8-B2B4-4400-A37E-FE0220D4E359Q33787646-B9BF1BBE-350B-4F3F-9911-FDA97458C482Q33792236-EA628931-E748-4182-B128-BFBAD0DFCC19Q33859987-32B86A62-6105-46A3-B1BD-84D0AEF83FF5Q36163886-1EC3B2FD-54CC-4A92-A850-2AD9486A3250Q36220750-B4285A52-17EB-4BCB-BE6C-BEEA3149FF14Q37500910-C1D11FAA-92B6-4DA0-A32B-C452C872F845Q37633151-22DC901A-9927-4119-B35D-80EFF02EC474Q37677218-D6F8F902-12E4-47FA-BC71-431A282AB336Q37714471-76BE9B16-CF18-472C-826C-322E13675ECEQ37834503-ABA22296-70D3-43FB-A522-AB6514D876C2Q38644764-A5D991D8-A9FA-4986-8CEA-AF7FB6A612E3Q38647754-0760C5B7-05A2-404C-A35B-206A0F0AA706Q38650577-E8134AEE-EED5-4C4D-8E33-FF022C7DAA44Q38657651-997D86AC-9E9F-4417-A14F-041E8F9B758AQ38700055-77677A9E-E1BE-43EB-B4B5-451EC332B742Q38729837-B79E694A-7641-4C3C-8C96-9EEC16C890BAQ38794124-2BD5E690-601D-4FA7-847A-EF4FF7AAA4EEQ38820326-5AEDC888-4EFE-4CDD-A1F4-7E728994DFA8Q38851798-A2E35EED-2A19-44A1-8A80-71F8C29D4DE5Q38869781-37077AE5-035E-460B-A1CE-5FC8E7EA4A38Q38943489-06F10C9D-AAFC-4C40-A16F-73F8B52D4E3AQ38984209-188F5FAB-CA9D-4639-8648-DD8AC6C50102Q38998796-A5D41D16-7357-4075-A7AA-B9139AC11C29Q39002230-361043F8-C55F-49B9-833F-76F225B7A4E5Q39041548-701EC48F-4BE3-46A2-A82F-E32873B17BAFQ39108740-E46D3590-2149-4DD7-B0DC-C6D1E8E3FB03Q39108779-B4F81965-C882-46FC-BA4F-8972DC243EAEQ39113856-5A3DEC23-669C-409B-B04E-0AB383DE3682Q39315697-57847C30-9567-474F-813F-AD7EDD771BCFQ40045681-C68D741D-5DC6-4D2C-A6C4-10C9BCFD11B4
P2860
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
@en
Antiretroviral Therapy for the Prevention of HIV-1 Transmission.
@nl
type
label
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
@en
Antiretroviral Therapy for the Prevention of HIV-1 Transmission.
@nl
prefLabel
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
@en
Antiretroviral Therapy for the Prevention of HIV-1 Transmission.
@nl
P2093
P2860
P50
P921
P356
P1476
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
@en
P2093
Andrew D Redd
Breno R Santos
David Burns
HPTN 052 Study Team
Irving F Hoffman
James G Hakim
Joel Gallant
Johnstone Kumwenda
Jose H S Pilotto
Leslie Cottle
P2860
P304
P356
10.1056/NEJMOA1600693
P407
P50
P577
2016-07-18T00:00:00Z